Modulators of Mad family Function: MIx and mSin3A

Mad 系列功能调制器:MIx 和 mSin3A

基本信息

  • 批准号:
    6888073
  • 负责人:
  • 金额:
    $ 26.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-05-01 至 2007-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The proto-oncoprotein Myc functions as a transcriptional regulator and is deregulated in many human cancers. A complex network of protein-protein and protein-DNA interactions controls Myc activity. Myc does not function on its own, but forms heterodimers with Max; Myc:Max regulates the expression of genes involved in cell division, growth and metabolism. Max has many protein partners including the Mad transcriptional repressors. We have identified a Max analog, Mlx. Like Max, Mlx interacts with Mad family members to repress transcription. Mlx also interacts with a novel family of transcription factors, the Mondo family. Mondo proteins may be functional analogs of Myc. Mondo proteins interact with Mlx and the Mondo:Mlx heterodimer can bind the same CACGTG E box element as Myc:Max and activate transcription. In Drosophila, dMondo and dMyc function in similar genetic pathways. In contrast to the nuclear localization of Myc:Max, Mondo:M1x localizes to the cytoplasm. Two novel domains are required the for cytoplasmic localization of Mondo:Mlx heterodimers: a novel conserved region in the N-terminus of the Mondo family members and a conserved domain in the C-terminus of both Mondo and Mlx proteins. We hypothesize that MondoA:Mlx functions similarly to Myc:Max in controlling cell growth, but its nuclear activity is under tight control by cytoplasmic sequestration. Furthermore, we hypothesize that Mondo:Mlx is released from the cytoplasm and accumulates in the nucleus in response to extracellular signals and that these signals impinge on the regulatory domain at the N-terminus of Mondo. We propose here to determine the proteins associated with MondoA:Mlx (Aim 1), perform structure-function analyses on the novel domains in Mondo and Mlx (Aim 2), investigate the biological function of Mondo:Mlx (Aim 3), and determine the signals that trigger MondoA:Mlx release from the cytoplasm (Aim 4). We propose a multidisciplinary approach using cell biological assays, global transcript analysis, biochemical purification and a novel reverse two-hybrid system.
描述(申请人提供):原癌蛋白Myc的功能是 转录调节因子,在许多人类癌症中被解除调控。一种情结 蛋白质-蛋白质和蛋白质-DNA相互作用网络控制着Myc的活动。 MYC本身不起作用,但与Max形成异二聚体;Myc:Max 调节参与细胞分裂、生长和生长的基因的表达 新陈代谢。Max有许多蛋白质伙伴,包括Mad转录 抑制者。我们已经确定了一种MAX模拟产品MLX。与MAX一样,MLX与 疯狂的家庭成员压制转录。MLX还与一部小说互动 转录因子家族,蒙多家族。Mondo蛋白可能是 Myc.的功能类似物Mondo蛋白与MLX及Mondo:MLX相互作用 异源二聚体可以结合与Myc:Max相同的CACGTG E盒元件并激活 抄写。在果蝇中,dMondo和dMyc的功能相似 小路。与Myc:Max,Mondo:M1x的核定位相反 定位于细胞质。细胞质所需的两个新结构域 Mondo:MLX异源二聚体的定位:一个新的保守区 Mondo家族成员的N-末端和C-末端的保守结构域 Mondo和MLX蛋白的同源性。我们假设Mondoa:MLX起作用 与Myc:Max在控制细胞生长方面类似,但其核活动是 在细胞质隔离的严格控制下。此外,我们假设 Mondo:MLX从细胞质中释放并在细胞核中积聚 对细胞外信号的反应,这些信号影响到 在Mondo的N-末端的调控结构域。我们在此建议确定 与Mondoa相关的蛋白质:MLX(Aim 1),执行结构功能 分析Mondo和MLX中的新结构域(Aim 2),研究 Mondo的生物学功能:MLX(目标3),并确定 触发Mondoa:MLX从细胞质中释放(目标4)。我们提出了一个 使用细胞生物学分析的多学科方法,全球转录 分析、生化纯化和一种新的反向双杂交系统。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donald E Ayer其他文献

Donald E Ayer的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donald E Ayer', 18)}}的其他基金

Huntsman Cancer Institute (HCI) Cancer Genetics, Epigenetics, Models, and Signaling (Cancer GEMS) Training Program
亨斯迈癌症研究所 (HCI) 癌症遗传学、表观遗传学、模型和信号传导(癌症 GEMS)培训计划
  • 批准号:
    10627604
  • 财政年份:
    2023
  • 资助金额:
    $ 26.91万
  • 项目类别:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
亨斯迈癌症研究所癌症研究 PathMaker 计划
  • 批准号:
    10474257
  • 财政年份:
    2019
  • 资助金额:
    $ 26.91万
  • 项目类别:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
亨斯迈癌症研究所癌症研究 PathMaker 计划
  • 批准号:
    9792209
  • 财政年份:
    2019
  • 资助金额:
    $ 26.91万
  • 项目类别:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
亨斯迈癌症研究所癌症研究 PathMaker 计划
  • 批准号:
    10661674
  • 财政年份:
    2019
  • 资助金额:
    $ 26.91万
  • 项目类别:
Huntsman Cancer Institute PathMaker Programs for Cancer Research
亨斯迈癌症研究所癌症研究 PathMaker 计划
  • 批准号:
    10005296
  • 财政年份:
    2019
  • 资助金额:
    $ 26.91万
  • 项目类别:
Nutrient Sensing and Transcriptional Regulation
营养感应和转录调节
  • 批准号:
    10421294
  • 财政年份:
    2018
  • 资助金额:
    $ 26.91万
  • 项目类别:
Nutrient Sensing and Transcriptional Regulation
营养感应和转录调节
  • 批准号:
    10174861
  • 财政年份:
    2018
  • 资助金额:
    $ 26.91万
  • 项目类别:
Transcriptional control of skeletal muscle insulin resistance
骨骼肌胰岛素抵抗的转录控制
  • 批准号:
    8299142
  • 财政年份:
    2010
  • 资助金额:
    $ 26.91万
  • 项目类别:
Transcriptional control of skeletal muscle insulin resistance
骨骼肌胰岛素抵抗的转录控制
  • 批准号:
    8463513
  • 财政年份:
    2010
  • 资助金额:
    $ 26.91万
  • 项目类别:
Transcriptional control of skeletal muscle insulin resistance
骨骼肌胰岛素抵抗的转录控制
  • 批准号:
    7918568
  • 财政年份:
    2010
  • 资助金额:
    $ 26.91万
  • 项目类别:

相似海外基金

Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10506915
  • 财政年份:
    2021
  • 资助金额:
    $ 26.91万
  • 项目类别:
Cellular membrane affinity chromatography kit for drug discovery
用于药物发现的细胞膜亲和层析试剂盒
  • 批准号:
    10325006
  • 财政年份:
    2021
  • 资助金额:
    $ 26.91万
  • 项目类别:
SBIR Phase I: A New Class of Immobilized Metal Affinity Chromatography Resins
SBIR 第一阶段:一类新型固定金属亲和色谱树脂
  • 批准号:
    1746198
  • 财政年份:
    2018
  • 资助金额:
    $ 26.91万
  • 项目类别:
    Standard Grant
Marine speciation of nickel using immobilized nickel affinity chromatography
使用固定镍亲和色谱法测定镍的海洋形态
  • 批准号:
    512537-2017
  • 财政年份:
    2017
  • 资助金额:
    $ 26.91万
  • 项目类别:
    University Undergraduate Student Research Awards
I-Corps: Commercialization of Immobilized Metal Affinity Chromatography Resins Based on Nanomaterials
I-Corps:基于纳米材料的固定化金属亲和层析树脂的商业化
  • 批准号:
    1404605
  • 财政年份:
    2014
  • 资助金额:
    $ 26.91万
  • 项目类别:
    Standard Grant
Antibody Purification via Affinity Chromatography that Utilizes the Unconventional Nucleotide Binding Site
利用非常规核苷酸结合位点通过亲和色谱法纯化抗体
  • 批准号:
    1263713
  • 财政年份:
    2013
  • 资助金额:
    $ 26.91万
  • 项目类别:
    Continuing Grant
Development of multivalent DNA network based affinity chromatography diagnostics for isolating circulating tumour cells
开发基于多价 DNA 网络的亲和色谱诊断法,用于分离循环肿瘤细胞
  • 批准号:
    425749-2012
  • 财政年份:
    2012
  • 资助金额:
    $ 26.91万
  • 项目类别:
    Postgraduate Scholarships - Master's
Next-Generation Affinity Chromatography with PEGylated Ligands
使用聚乙二醇化配体的新一代亲和色谱法
  • 批准号:
    1159886
  • 财政年份:
    2012
  • 资助金额:
    $ 26.91万
  • 项目类别:
    Standard Grant
Immobilized zirconium ion affinity chromatography for specific enrichment of phosphoproteins
用于磷蛋白特异性富集的固定化锆离子亲和层析
  • 批准号:
    19560760
  • 财政年份:
    2007
  • 资助金额:
    $ 26.91万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating drug discovery using frontal affinity chromatography/mass spectrometry
使用正面亲和色谱/质谱加速药物发现
  • 批准号:
    234753-2000
  • 财政年份:
    2003
  • 资助金额:
    $ 26.91万
  • 项目类别:
    Collaborative Research and Development Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了